544. Chiesa R, et al. (2023) N Engl J Med. Epub ahead of print. 545. Vasan N, et al. (2019) Nature, 575: 299. 546. Jin H, et al. (2023) Nat Rev Drug Discov, 22: 213. 547. Obenauf AC (2022) Sci Transl Med, 14: eadd0887. 548. Upadhaya S, et al. (2022) Nat Rev Drug Discov, 21: 482. 549. Zhu S, et al. (2021) J Hematol Oncol, 14: 156. 550. Bilusic M, et al. (2021) J Natl Cancer Inst, 113: 799. 551. Higham CE, et al. (2020) Eur J Cancer, 132: 207. 552. Lu Y, et al. (2022) J Hematol Oncol, 15: 47. 553. Li B, et al. (2023) Cancers (Basel), 15. 554. Cortes J, et al. (2022) N Engl J Med, 387: 217. 555. ClinicalTrials.gov. Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/ Unresectable Stage III NSCLC. Accessed: July 31, 2023. Available from: https://www.clinicaltrials.gov/study/ NCT02343952. 556. Murphy CC, et al. (2023) JAMA Oncol, 9: 1147. 557. Ellington TD, et al. (2023) PLoS One, 18: e0284051. 558. Patel VR, et al. (2023) JAMA Oncol, 9: 1001. 559. Ni J, et al. (2020) Cancer Manag Res, 12: 5597. 560. Law ML (2022) Front Pain Res (Lausanne), 3: 971295. 561. National Cancer Institute. Treating Cancer Cachexia: Progress Looks Possible. Accessed: July 5, 2023. Available from: https://www.cancer.gov/about-cancer/treatment/ research/cachexia. 562. Chiaravalloti A, et al. (2023) J Nucl Med, 64: 508. 563. Lange M, et al. (2023) J Natl Cancer Inst, 115: 322. 564. Scott LC, et al. (2021) MMWR Morb Mortal Wkly Rep, 70: 1. 565. Zhu C, et al. (2023) JACC CardioOncol, 5: 55. 566. Lozano AX, et al. (2022) Nat Med, 28: 353. 567. Bryan CJ, et al. (2023) JAMA Oncol, 9: 303. 568. Rincones O, et al. (2021) Cancer Manag Res, 13: 3803. 569. Papini C, et al. (2023) Cancer, 129: 1117. 570. Chang WH, et al. (2022) Nat Med, 28: 860. 571. Chan ASW, et al. (2022) Front Public Health, 10: 912980. 572. Potter AL, et al. (2023) JAMA Oncol, 9: 308. 573. Andersen BL, et al. (2022) Psychosom Med, 84: 215. 574. Andersen BL, et al. (2023) PLoS One, 18: e0282206. 575. Breitbart W, et al. (2014) Psychooncology, 23: 339. 576. McFarland DC, et al. (2022) Cancer, 128: 2504. 577. Galea I (2021) Cell Mol Immunol, 18: 2489. 578. Yabroff KR, et al. (2022) J Natl Cancer Inst, 114: 863. 579. Shih YT, et al. (2022) J Natl Cancer Inst, 114: 1392. 580. Grabowski DC, et al. (2023) JAMA Netw Open, 6: e2315823. 581. Ehsan AN, et al. (2023) JAMA Netw Open, 6: e2255388. 582. Graboyes EM, et al. (2022) J Natl Cancer Inst, 114: 1593. 583. Fan Q, et al. (2022) J Natl Cancer Inst, 114: 1584. 584. Raber M, et al. (2022) J Natl Cancer Inst, 114: 1577. 585. Ghazal LV, et al. (2023) JAMA Netw Open, 6: e235897. 586. Bradley CJ, et al. (2023) J Clin Oncol, 41: 2939. 587. Siegel RL, et al. (2021) CA Cancer J Clin, 71: 7. 588. Armstrong GT, et al. (2014) J Clin Oncol, 32: 1218. 589. Hudson MM, et al. (2013) JAMA, 309: 2371. 590. Meijer AJM, et al. (2022) Cancer, 128: 169. 591. Schulte F, et al. (2022) JAMA Netw Open, 5: e2227225. 592. Dixon SB, et al. (2023) Lancet, 401: 1447. 593. Williams AM, et al. (2023) J Natl Cancer Inst, 115: 200. 594. Plonski NM, et al. (2023) JAMA Netw Open, 6: e2310325. 595. Hsu TW, et al. (2023) J Clin Oncol, 41: 2054. 596. National Cancer Institute. Cancer Among Adolescents and Young Adults (AYAs). Accessed: Jul 5, 2023. Available from: https://seer.cancer.gov/statfacts/html/aya. html. 597. Chao C, et al. (2020) J Clin Oncol, 38: 3161. 598. Xie J, et al. (2022) Cancer Med, 11: 3508. 599. Alliance for Fertility Preservation. State Laws & Legislation. Accessed: July 31, 2023. Available from: https://www.allianceforfertilitypreservation.org/statelegislation/. 600. Stensheim H, et al. (2009) J Clin Oncol, 27: 45. 601. Jorgensen K, et al. (2022) Obstet Gynecol, 140: 939. 602. Betts AC, et al. (2023) J Natl Cancer Inst, 115: 619. 603. Anderson C, et al. (2017) JAMA Oncol, 3: 1078. 604. Partridge AH, et al. (2023) N Engl J Med, 388: 1645. 605. Ryder-Burbidge C, et al. (2021) Cancers (Basel), 13. 606. Berkman AM, et al. (2023) J Natl Cancer Inst, 115: 447. 607. Meernik C, et al. (2023) J Adolesc Young Adult Oncol. AACR Cancer Progress Report 2023 References 178
RkJQdWJsaXNoZXIy NTkzMzk=